Director Brad Thompson resigns from Enveric Biosciences board

Enveric Biosciences, Inc.

Brad Thompson, PhD resigned from the board of directors on May 3, 2022.
Resignation was not due to any disagreement regarding the Company's operations, policies, or practices.
No replacement for Dr. Thompson has been announced in the filing.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Brad Thompson

Director

ENVB · Enveric Biosciences, Inc.

Effective: 2022-05-03
Filed: May 4, 2022, 7:59 PM ET

On May 3, 2022, Brad Thompson, PhD resigned from the board of directors (the “ Board ”) of Enveric Biosciences, Inc. (the “ Company ”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Brad Thompson resigned as Director at Enveric Biosciences, Inc..

Action: resigned
Role: Director

Exact text from the filing

On May 3, 2022, Brad Thompson, PhD resigned from the board of directors (the “ Board ”) of Enveric Biosciences, Inc. (the “ Company ”).

View on SEC.gov

Enveric Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-22-012127

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.